News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
153,391 Results
Type
Article (11986)
Company Profile (52)
Press Release (141353)
Section
Business (49226)
Career Advice (1387)
Deals (7484)
Drug Delivery (39)
Drug Development (22060)
Employer Resources (92)
FDA (4073)
Job Trends (4387)
News (82476)
Policy (7022)
Tag
Academia (817)
Alliances (9593)
Alzheimer's disease (401)
Approvals (4078)
Artificial intelligence (71)
Bankruptcy (52)
Best Places to Work (3750)
Breast cancer (89)
Cancer (608)
Cardiovascular disease (42)
Career advice (1160)
Cell therapy (122)
Clinical research (18404)
Collaboration (211)
Compensation (113)
COVID-19 (821)
C-suite (47)
Data (612)
Diabetes (69)
Diagnostics (1639)
Earnings (22803)
Employer resources (82)
Events (20351)
Executive appointments (180)
FDA (4357)
Funding (230)
Gene therapy (87)
GLP-1 (235)
Government (1223)
Healthcare (4903)
Infectious disease (859)
Inflammatory bowel disease (43)
Interviews (244)
IPO (4220)
Job creations (912)
Job search strategy (972)
Layoffs (124)
Legal (1101)
Lung cancer (85)
Lymphoma (50)
Manufacturing (87)
Medical device (3372)
Medtech (3372)
Mergers & acquisitions (3391)
Metabolic disorders (195)
Neuroscience (525)
NextGen Class of 2024 (1997)
Non-profit (1377)
Northern California (680)
Obesity (103)
Opinion (123)
People (12959)
Phase I (5342)
Phase II (7779)
Phase III (6875)
Pipeline (236)
Policy (44)
Postmarket research (818)
Preclinical (1658)
Radiopharmaceuticals (69)
Rare diseases (110)
Real estate (1495)
Regulatory (5151)
Research institute (702)
Resumes & cover letters (236)
Series A (48)
Southern California (523)
Startups (1713)
United States (5390)
Vaccines (211)
Weight loss (76)
Date
Last 7 days (281)
Last 30 days (1099)
Last 365 days (11858)
2024 (11824)
2023 (11319)
2022 (13833)
2021 (14428)
2020 (14140)
2019 (12281)
2018 (8922)
2017 (8397)
2016 (7780)
2015 (8583)
2014 (5971)
2013 (4450)
2012 (4769)
2011 (5024)
2010 (3913)
Location
Africa (320)
Asia (12794)
Australia (1852)
California (1500)
Canada (420)
China (118)
Colorado (80)
Connecticut (88)
Delaware (61)
Europe (27525)
Florida (183)
Georgia (40)
Illinois (133)
Indiana (83)
Japan (43)
Maryland (182)
Massachusetts (1061)
Michigan (41)
Minnesota (88)
New Jersey (428)
New York (403)
North Carolina (209)
Northern California (680)
Ohio (42)
Pennsylvania (308)
South America (386)
Southern California (523)
Texas (206)
Washington State (112)
153,391 Results for "f star".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
F-star Therapeutics , an invoX company (“F-star”) , today announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda.
July 5, 2023
·
4 min read
Press Releases
Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024
December 9, 2024
·
6 min read
Business
Takeda, F-star Sign Potential $1B Immuno-Oncology Agreement
The companies have signed two other pacts over the last year. In the latest deal, Takeda gains access to F-star’s platform to produce tetravalent antibodies for undisclosed oncology targets.
July 6, 2023
·
2 min read
·
Tristan Manalac
Press Releases
Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
December 10, 2024
·
6 min read
Biotech Bay
Star Therapeutics Presents Clinical Data for VGA039, a Subcutaneous Therapy for the Treatment of Von Willebrand Disease (VWD)
Star Therapeutics today announced the presentation of clinical data from VIVID 1 (VGA039 Investigation in Von Willebrand Disease), a Phase 1 clinical study of VGA039 in healthy volunteers.
June 26, 2024
·
4 min read
Press Releases
Darmiyan Enters Medicare GUIDE Program Through Partnership with Five Star Home Health Care, CareBrains, and Brain Watch Coalition
December 19, 2024
·
2 min read
Press Releases
Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE
December 11, 2024
·
10 min read
Press Releases
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
December 3, 2024
·
6 min read
Deals
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces that it has successfully completed the acquisition of F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX).
March 8, 2023
·
6 min read
Drug Development
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced positive initial proof-of-concept results from the ALPHA-STAR Phase 1b/2 clinical trial evaluating STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, in hereditary angioedema (HAE) patients.
March 25, 2024
·
12 min read
1 of 15,340
Next
